Ken Griffin Sanara Med Tech Inc. Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 22,773 shares of SMTI stock, worth $625,574. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,773
Previous 15,423
47.66%
Holding current value
$625,574
Previous $476,000
35.71%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding SMTI
# of Institutions
50Shares Held
953KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$5.41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$4.83 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA77.7KShares$2.14 Million0.0% of portfolio
-
Marshall Wace, LLP London, X071.5KShares$1.96 Million0.0% of portfolio
-
State Street Corp Boston, MA65.3KShares$1.79 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $228M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...